https://wiki.cakele.iodatalabs.dev/w/index.php?action=history&feed=atom&title=DGI%3ABorreliose%2FKardiale_und_arthrogene_Manifestation%2FQuellen 2026-09-03T21:02:49Z Versionsgeschichte dieser Seite in Infektiopedia MediaWiki 1.43.9 https://wiki.cakele.iodatalabs.dev/w/index.php?title=DGI:Borreliose/Kardiale_und_arthrogene_Manifestation/Quellen&diff=9831&oldid=prev 2025-03-06T13:39:37Z

<p>Die Seite wurde geleert.</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de-x-formal"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 6. März 2025, 13:39 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am. 2015;29(2):269-280. doi:10.1016/j.idc.2015.02.004</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 2006;54(10):3079-3086. doi:10.1002/art.22131</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Grillon A, Scherlinger M, Boyer PH, et al. Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis. Semin Arthritis Rheum. 2019;48(6):1105-1112. doi:10.1016/j.semarthrit.2018.09.007</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Hofmann H, et al. S2k-Leitlinie Kutane Lyme Borreliose, 2016</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Rauer S, Kastenbauer S. S3-Leitlinie Neuroborreliose, 2018</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Kullberg BJ, et al., Lyme borreliosis: diagnosis and treatment. BMJ, 2020. 369:m1041. doi: 10.1136/bmj.m1041.  </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Gaubitz M, et al., Empfehlungen der DGRh zur Therapie der Lyme-Borreliose, speziell des Erythema migrans sowie der Lyme-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• NICE guideline 2018: Lyme disease</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Goodlet KJ, Fairman KA. Adverse Events Associated With Antibiotics and Intravenous Therapies for Post–Lyme Disease Syndrome in a Commercially Insured Sample. Clin Infect Dis, 2018; 67(10):1568-1574</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Cook MJ. Lyme borreliosis: a review of data on transmission time after tick attachment.  Int J Gen Med. 2014 Dec 19;8:1-8</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Rahlenbeck S, Fingerle V „Ixodes ricinus Wie man sich vor Zecken schützt“ Deutsches Ärzteblatt Jg. 111 Heft 25 A 1142- A 1143</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• AWMF Leitlinie der Deutschen Dermatologischen Gesellschaft AWMF-Register-Nr. 013/044 Klasse: S2k „Kutane Lyme Borreliose“ https://www.awmf.org/uploads/tx_szleitlinien/013-044l_S2k_Kutane_Lyme_Borreliose_2016-05.pdf (letzter Zugriff: )</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">• Nau R, Christen HJ, Eiffert H „Lyme Disease – Current State of Knowledge“ Dtsch Ärztebl Int 2009; 106(5): 72-82 (Diskussion: https://www.aerzteblatt.de/pdf.asp?id=65524)</del></div></td><td colspan="2" class="diff-side-added"></td></tr> </table>

Brinkery https://wiki.cakele.iodatalabs.dev/w/index.php?title=DGI:Borreliose/Kardiale_und_arthrogene_Manifestation/Quellen&diff=9830&oldid=prev 2025-03-06T13:39:21Z

<p>Die Seite wurde neu angelegt: „ • Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am. 2015;29(2):269-280. doi:10.1016/j.idc.2015.02.004 • Steere A…“</p> <p><b>Neue Seite</b></p><div><br /> • Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am. 2015;29(2):269-280. doi:10.1016/j.idc.2015.02.004<br /> • Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 2006;54(10):3079-3086. doi:10.1002/art.22131<br /> • Grillon A, Scherlinger M, Boyer PH, et al. Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis. Semin Arthritis Rheum. 2019;48(6):1105-1112. doi:10.1016/j.semarthrit.2018.09.007<br /> • Hofmann H, et al. S2k-Leitlinie Kutane Lyme Borreliose, 2016<br /> • Rauer S, Kastenbauer S. S3-Leitlinie Neuroborreliose, 2018<br /> • Kullberg BJ, et al., Lyme borreliosis: diagnosis and treatment. BMJ, 2020. 369:m1041. doi: 10.1136/bmj.m1041. <br /> • Gaubitz M, et al., Empfehlungen der DGRh zur Therapie der Lyme-Borreliose, speziell des Erythema migrans sowie der Lyme-<br /> • NICE guideline 2018: Lyme disease<br /> • Goodlet KJ, Fairman KA. Adverse Events Associated With Antibiotics and Intravenous Therapies for Post–Lyme Disease Syndrome in a Commercially Insured Sample. Clin Infect Dis, 2018; 67(10):1568-1574<br /> • Cook MJ. Lyme borreliosis: a review of data on transmission time after tick attachment. Int J Gen Med. 2014 Dec 19;8:1-8<br /> • Rahlenbeck S, Fingerle V „Ixodes ricinus Wie man sich vor Zecken schützt“ Deutsches Ärzteblatt Jg. 111 Heft 25 A 1142- A 1143<br /> • AWMF Leitlinie der Deutschen Dermatologischen Gesellschaft AWMF-Register-Nr. 013/044 Klasse: S2k „Kutane Lyme Borreliose“ https://www.awmf.org/uploads/tx_szleitlinien/013-044l_S2k_Kutane_Lyme_Borreliose_2016-05.pdf (letzter Zugriff: )<br /> • Nau R, Christen HJ, Eiffert H „Lyme Disease – Current State of Knowledge“ Dtsch Ärztebl Int 2009; 106(5): 72-82 (Diskussion: https://www.aerzteblatt.de/pdf.asp?id=65524)</div>

Brinkery